Search
Search Constraints
You searched for: Is Part Of Gut. Volume 56:Issue 7(2007)Limit your search
- 616.33 46
- Gastroenterology -- Periodicals 46
- A, necroinflammatory activity -- ALT, alanine aminotransferase -- AST, aspartate aminostransferase -- BMI, body mass index -- CLD, chronic liver disease -- F, fibrosis stage -- GGTP, and gammaglutamiltransferase -- HBV, hepatitis B virus -- HCV, hepatitis B virus -- ICC, intraclass correlation coefficient -- IQR, interquartile range -- NASH, non-alcoholic steatohepatitis -- ROC, receiver operating characteristic -- TE, transient elastography -- US, ultrasonography 1
- ALF, acute liver failure -- ALT, alanine aminotransferase -- AP-1, activating protein 1 -- CCl4, carbon tetrachloride -- d-JNKI1, c-jun N-terminal kinase peptide inhibitor 1, d-stereoisomer -- IP, intraperitoneal -- JNK, c-jun (NH2) terminal kinase -- NAC, N-acetylcysteine -- NAPQI, N-acetyl-p-quinoneimine -- PBS, phosphate-buffered saline -- ROS, reactive oxygen species -- TNFα, tumour necrosis factor α -- TNFR1, TNF receptor 1 -- WT, wild type 1
- ALT, alanine aminotransferase -- cDNA, complementary DNA -- COX, cyclo-oxygenase -- IL, interleukin -- IP-10, interferon-γ-inducible protein-10 -- MIP-2, macrophage inflammatory protein-2 -- NF-κB, nuclear factor-kappaB -- PI, proliferation index -- PGE2, prostaglandin E2 -- TG, transgenic -- TGF-β1, transforming growth factor-β1 -- TNF-α, tumour necrosis factor-α -- TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-digoxigenin nick end labelling -- WT, wild type 1
- ALT, alanine transaminase -- AST, aspartate aminotransferase -- CCl4, carbon tetrachloride -- CNS, central nervous system -- ConA, concanavalin A -- DAMGO or DO, [d-Ala2, NMe-Phe4, Gly5-ol]-enkephalin -- DOR, Δ-opioid receptor -- IBD, inflammatory bowel disease -- IFN, interferon -- IL, interleukin -- KOR, κ-opioid receptor -- LDH, lactate dehydrogenase -- MOR, μ-opioid receptor -- NF-κB, nuclear factor κB -- NK, natural killer -- NM, naloxone methiodide -- TNFα, tumour necrosis factor α -- TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling 1
- ANOVA, analysis of variance -- CGA, chromogranin A -- EC, enterochromaffin -- GI, gastrointestinal -- 5-HT, 5-hydroxytryptamine -- IBS, irritable bowel syndrome -- IL, interleukin -- IL4R, interleukin 4 receptor -- IL-13Rα1, interleukin 13 receptor α1-chain -- LCM, laser capture microdissection -- PBS, phophate-buffered saline -- PI, post-infectious -- RT, room temperature -- RT-PCR, reverse transcription PCR -- SCID, severe combined immunodeficient -- Th2, T helper 2 1
- AP-1, activator-protein 1 -- CER, caerulein -- EMSA, electrophoretic mobility-shift assay -- LRGILS, leucine-arginine-glycine-isoleucine-leucine-serine -- MOPS, 3-(N-morpholino)-propane sulphonic acid -- NFκB, nuclear factor kappa B -- PAR-2, protease-activated receptor 2 -- SLIGRL, serine-leucine-isoleucine-glycine-arginine-leucine -- TBE, tris-borate buffer 1
- APC, adenomatous polyposis coli -- BRAF, B-Raf mutations -- CIMP, CpG island methylator phenotype -- HNPCC, hereditary non-polyposis colorectal cancer -- IHC, immunohistochemistry -- KRAS, K-ras mutation -- LOH, loss of heterozygosity -- MLPA, multiplex ligation-dependent probe amplification -- MMR, DNA mismatch repair -- MSI, microsatellite instability -- MS-MLPA, methylation-specific MLPA -- MSS, microsatellite stable -- SNuPE, single nucleotide primer extension 1
- ASF, altered Schaedler flora -- DF, defined flora -- ELISA, enzyme-linked immunosorbent assay -- FBS, fetal bovine serum -- IBD, inflammatory bowel disease -- IFNγ, interferon γ -- IL, interleukin -- MLN, mesenteric lymph node -- NI, non-infected -- PBS, phophate-buffered saline -- PBST, phosphate-buffered saline Tween 20 -- PI, postinfection -- SPF, specific pathogen-free -- SPL, spleen 1